Q MED LABORATORY LLC NPI 1386817435

NPI Information

  • NPI: 1386817435
  • Provider Name: Q MED LABORATORY, LLC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • CLIA Number: 45D1081814
  • Address: 11355 MONTWOOD DR
    SUITE E
    EL PASO, TX
    ZIP 79936
  • Phone: (915) 855-2454

Map and Directions

Get Directions

NPI Details

Q MED LABORATORY, LLC is a clinical medical laboratory in El Paso, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. Q MED LABORATORY, LLC NPI is 1386817435. The provider is registered as an organization entity type.

The provider's business location address is:

11355 MONTWOOD DR
SUITE E
EL PASO, TX
ZIP 79936-876
Phone: (915) 855-2454

The provider's authorized official is Susana I Oman .
The authorized official title is President and has the following contact phone number (915) 855-2454.

The CLIA number assigned to this NPI record is 45D1081814 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Vitamin d-3 level (HCPCS:82306)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Hemoglobin a1c level (HCPCS:83036)
  • Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) (HCPCS:G0471)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Ldl cholesterol level (HCPCS:83721)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Urine microalbumin (protein) level (HCPCS:82043)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Folic acid level, serum (HCPCS:82746)
  • Creatinine clearance measurement to test for kidney function (HCPCS:82575)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
  • Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
  • Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled (HCPCS:P9603)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Bacterial urine culture (HCPCS:87088)
  • Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets (HCPCS:87505)
  • Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge (HCPCS:P9604)
  • Iron level (HCPCS:83540)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Blood test, clotting time (HCPCS:85610)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Magnesium level (HCPCS:83735)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
  • Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge (HCPCS:P9604)
  • Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
  • Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
  • Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
  • Iron binding capacity (HCPCS:83550)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Liver function blood test panel (HCPCS:80076)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
  • Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Rheumatoid factor level (HCPCS:86431)
  • Kidney function blood test panel (HCPCS:80069)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Ammonia level (HCPCS:82140)
  • Test for detection of infectious agent antibody, qualitative or semiquantitative (HCPCS:86318)
  • Rheumatoid factor analysis (HCPCS:86430)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative (HCPCS:86328)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Thyroid hormone, t3 measurement, total (HCPCS:84480)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
  • Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) (HCPCS:G0471)
  • Urinalysis for bacteria (HCPCS:81007)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)

The enumeration date for this NPI number is 4/9/2008 and was last updated on 3/14/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1291U00000XClinical Medical Laboratory45D1081814TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.